A non-destructive test to predict if your stem cells can become retinal cells
Non-destructive assessment of retinal differentiation capacity and developmental maturity
This work uses robotic cell culture, imaging, and AI to predict which patient-derived stem cells will successfully turn into retinal cells for people with inherited retinal blindness.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Iowa NIH-funded |
| Lab location | 1 site (Iowa City, United States) |
| Project ID | NIH-11285273 on NIH RePORTER |
What this research studies
If you donate skin or blood cells, researchers will reprogram them into iPSCs and grow them on an automated robotic platform that takes regular images without harming the cells. They will train AI models to read those images and identify signs that a cell line will or will not become mature retinal cells. The goal is to pick the best patient-specific cell lines early so only promising lines move forward to make retinal replacement tissues. This approach aims to cut time and cost and improve reliability for future autologous retinal therapies.
Who could benefit from this research
Good fit: People with inherited retinal degenerative conditions who can provide tissue or blood samples to make patient-specific iPSCs or who may be future recipients of autologous retinal cell therapies.
Not a fit: Patients whose vision loss is not due to replaceable retinal cell loss, those who cannot provide suitable cells, or those ineligible for cell therapies may not directly benefit.
Why it matters
Potential benefit: Could make autologous retinal cell therapies faster, less expensive, and more reliable, increasing the chance of restoring vision for people with inherited retinal degeneration.
How similar studies have performed: Robotic culture and iPSC-derived retinal cell production have precedent, but using non-destructive imaging plus AI to predict line-to-line success is relatively new.
Where this research is happening
Iowa City, United States
- University of Iowa — Iowa City, United States (Active)
Researchers
- Principal investigator: Tucker, Budd a — University of Iowa
- Study coordinator: Tucker, Budd a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.